• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Absence of coronary plaque among symptomatic patients with high low-density lipoprotein cholesterol levels associated with low risk of atherosclerotic cardiovascular disease events

byYuchen DaiandMichael Pratte
February 14, 2022
in Cardiology, Chronic Disease, Emergency
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Among symptomatic patients with high low-density lipoprotein cholesterol levels considered high risk for atherosclerotic cardiovascular disease (ASCVD), absence of calcified and noncalcified coronary plaque was associated with very low ASCVD event rates.

2. These results highlight the multifactorial nature of atherosclerotic cardiovascular disease being not only driven by low-density lipoprotein cholesterol levels, despite their causal pathophysiological role.

Evidence Rating Level: 2 (Good)

Study Rundown: Levels of low-density lipoprotein cholesterol (LDL-C) and coronary artery calcium (CAC) are frequent parameters used to assess atherosclerosis burden associated with the risk for atherosclerotic cardiovascular disease (ASCVD) events. Recent preliminary findings have suggested that some individuals with high LDL-C are resilient to developing calcified coronary plaque, as identified by a CAC score of 0. Despite this, there are concerns regarding the prevalence of noncalcified plaque in individuals with severe dyslipidemias despite a CAC score of 0. This study determined the prevalence of noncalcified and calcified plaque in symptomatic adults undergoing coronary computed tomographic angiography (CCTA) evaluation and assessed its association with ASCVD events (myocardial infarction and stroke) and death across the LDL-C spectrum. Among 23,143 symptomatic patients, absence of CAC and noncalcified plaque was prevalent in individuals with severely elevated LDL-C levels. Across the LDL-C spectrum, absence of CAC was associated with low rates of ASCVD and death, with higher rates in patients with greater CAC burden. These results highlight the multifactorial nature of ASCVD as it is not only driven by LDL-C levels, despite their causal pathophysiological role. A limitation of this study was that only symptomatic patients were included in the analysis, thus, the reported frequency of plaque and associated ASCVD events may be overstated and not representative of the asymptomatic population undergoing primary prevention.

Click to read the study in JAMA Network Open

Click to read an accompanying editorial in JAMA Network Open

RELATED REPORTS

Patients with gastric cancer may be at higher risk of cardiovascular death

Longer bouts of exercise may be associated with decreased mortality and cardiovascular disease

An absence of cardiovascular risk factors is linked to over ten additional healthy years

Relevant Reading: Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis

In-Depth [retrospective cohort]: This cohort study included 23,143 symptomatic patients (median age [IQR], 58 [50-65] years; 12,857 [55.6%] women) undergoing CCTA between 2008 to 2017 from the Western Denmark Heart Registry. The study evaluated the prevalence of calcified and noncalcified plaque across LDL-C categories of <77, 77-112, 113-154, 155-189, and ≥190 mg/dL, where the severity of coronary artery disease was assessed via CAC scores (higher numbers indicate greater CAC burden). Overall, 1,029 ASCVD and death events occurred during a median follow-up of 4.2 years. Across the LDL-C spectrum, absence of CAC was prevalent, ranging from 46.2% in ≥190 mg/dL cohort to 54.9% in 77-112 mg/dL cohort and associated with no detectable plaque in most patients, ranging from 77.2% in ≥190 mg/dL cohort to 88.6% in <77mg/dL cohort. Across all LDL-C categories, absence of CAC was associated with low rates of ASCVD and death (6.3 [95%CI, 5.6-7.0] per 1000 person-years), with higher rates in patients with CAC scores of 1 to 99 (11.1 [95%CI, 10.0-12.5] per 1000 person-years) and ≥100 (21.9 [95%CI, 19.9-24.4] per 1000 person-years). Among those with CAC scores of 0, the event rate per 1000 person-years was 6.3 (95%CI, 5.6-7.0) in the overall population compared to 6.9 (95%CI, 4.0-11.9) in those with LDL-C ≥190 mg/dL. Across the LDL-C spectrum, rates were similar and low in those with CAC scores of 0, regardless of plaque characteristics.

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: atherosclerorsisatherosclerotic plaquecardiovascular diseaselow density lipoprotein (LDL)
Previous Post

Cemiplimab treatment of recurrent cervical cancer is associated with longer overall survival

Next Post

The relationship between mental health and religiosity may not be bi-directional

RelatedReports

Cardiology

Patients with gastric cancer may be at higher risk of cardiovascular death

January 13, 2026
Home-based walking program an effective treatment for peripheral artery disease
Cardiology

Longer bouts of exercise may be associated with decreased mortality and cardiovascular disease

October 27, 2025
Cardiology

An absence of cardiovascular risk factors is linked to over ten additional healthy years

September 2, 2025
Prevalence of hypertension among adolescents varies by race and BMI
Cardiology

Intensive systolic blood pressure targets may be cost-effective across most measurement error possibilities

August 22, 2025
Next Post
Children’s hospital visits for suicide ideation and attempts are increasing

The relationship between mental health and religiosity may not be bi-directional

Cervical cancer screening practices less cost-effective than suggested guidelines

Pembrolizumab improves survival outcomes in cervical cancer patients

#VisualAbstract: Fulvestrant plus cyclin-dependent kinase 4/6 inhibitors improves survival in HR⁺, HER2- metastatic breast cancer

#VisualAbstract: Fulvestrant plus cyclin-dependent kinase 4/6 inhibitors improves survival in HR⁺, HER2- metastatic breast cancer

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind February 2, 2026
  • Sleeve gastrectomy may produce greater and more durable weight loss than semaglutide in patients with obesity
  • Fluoxetine may improve hemodynamic status and organ dysfunction in patients with severe sepsis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.